Your browser doesn't support javascript.
loading
Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk.
Johansson, Annelie; Palli, Domenico; Masala, Giovanna; Grioni, Sara; Agnoli, Claudia; Tumino, Rosario; Giurdanella, Maria Concetta; Fasanelli, Francesca; Sacerdote, Carlotta; Panico, Salvatore; Mattiello, Amalia; Polidoro, Silvia; Jones, Michael E; Schoemaker, Minouk J; Orr, Nick; Tomczyk, Katarzyna; Johnson, Nichola; Fletcher, Olivia; Perduca, Vittorio; Baglietto, Laura; Dugué, Pierre-Antoine; Southey, Melissa C; Giles, Graham G; English, Dallas R; Milne, Roger L; Severi, Gianluca; Ambatipudi, Srikant; Cuenin, Cyrille; Chajès, Veronique; Romieu, Isabelle; Herceg, Zdenko; Swerdlow, Anthony J; Vineis, Paolo; Flanagan, James M.
Afiliación
  • Johansson A; Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, 4th Floor IRDB, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
  • Palli D; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network-ISPRO, Florence, Italy.
  • Masala G; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network-ISPRO, Florence, Italy.
  • Grioni S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tumino R; Ragusa Cancer Registry, ASP, Ragusa, Italy.
  • Giurdanella MC; Ragusa Cancer Registry, ASP, Ragusa, Italy.
  • Fasanelli F; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Panico S; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Frederico II, Naples, Italy.
  • Mattiello A; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Frederico II, Naples, Italy.
  • Polidoro S; Italian Institute for Genomic Medicine, Turin, Italy.
  • Jones ME; The Institute of Cancer Research, London, UK.
  • Schoemaker MJ; The Institute of Cancer Research, London, UK.
  • Orr N; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Tomczyk K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Fletcher O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Perduca V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Baglietto L; MAP5 - UMR CNRS 8145, Université Paris Descartes, Paris, France.
  • Dugué PA; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Southey MC; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • English DR; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
  • Milne RL; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
  • Severi G; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Australia.
  • Ambatipudi S; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Cuenin C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Chajès V; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Romieu I; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Herceg Z; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Swerdlow AJ; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Vineis P; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Australia.
  • Flanagan JM; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
Clin Epigenetics ; 11(1): 66, 2019 04 30.
Article en En | MEDLINE | ID: mdl-31039828
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Metilación de ADN / Estrógenos / Estudio de Asociación del Genoma Completo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Epigenetics Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Metilación de ADN / Estrógenos / Estudio de Asociación del Genoma Completo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Epigenetics Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido